We are live on ! Find out more
CRVO icon

CervoMed

22 hedge funds and large institutions have $5.14M invested in CervoMed in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

394% more capital invested

Capital invested by funds: $1.04M → $5.14M (+$4.1M)

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

29% more funds holding

Funds holding: 1722 (+5)

0.01% less ownership

Funds ownership: 0.13%0.12% (-0.01%)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
6
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SRCM
26
Swift Run Capital Management
Virginia
-$5K -194 Closed
PAG
27
Private Advisor Group
New Jersey
-$4K -173 Closed
Two Sigma Advisers
28
Two Sigma Advisers
New York
-$4K -172 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
-$4K -154 Closed

CRVO Hedge Fund Activity: Q2 2020 in Review

22 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2020, worth a combined $5.14M — up 394% from $1.04M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRVO positions and 8 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.19M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $119K sold.

  • 22 institutional investors held CervoMed (CRVO) as of Q2 2020, up from 17 in Q1 2020.
  • Funds reported $5.14M of CervoMed stock for Q2 2020, up 394% quarter-over-quarter.
  • 13 funds opened new CervoMed positions in Q2 2020 and 8 closed out, a net change of +5 holders.
  • The largest CervoMed buyer in Q2 2020 was Renaissance Technologies, an estimated $1.19M added.
  • The largest CervoMed seller in Q2 2020 was Acadian Asset Management, an estimated $119K sold.

Based on aggregated 13F filings for Q2 2020.